Saphena Medical

Saphena Medical

Young, energetic company with deep knowledge in the cardiovascular space. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$8—13m (Dealroom.co estimates Jun 2018.)
West Bridgewater Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$970k

Series A
N/A

$1.3m

Debt

$1.8m

Series B
N/A

$2.7m

Debt

$1.3m

Series C
N/A

$2.1m

Series D
Total Funding$6.2m

Recent News about Saphena Medical

Edit
More about Saphena Medicalinfo icon
Edit

Saphena Medical specializes in developing and manufacturing the Venapax Endoscopic Vessel Harvesting (EVH) system, which is designed to improve the quality of veins harvested for cardiovascular procedures. The company primarily serves hospitals and cardiovascular institutes, providing them with advanced medical devices that enhance surgical outcomes. Operating in the medical device market, Saphena Medical's business model revolves around the sale and distribution of its proprietary Venapax system. Revenue is generated through direct sales to healthcare institutions and through contracts with purchasing programs like Premier SURPASS. The Venapax system is praised for its ability to minimize vein distortion and reduce leg wound complications, making it a preferred choice among seasoned harvesters and medical professionals.

Keywords: EVH system, vein quality, cardiovascular procedures, medical devices, hospitals, healthcare, surgical outcomes, Premier SURPASS, vein harvesting, USA manufacturing.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.